{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:09:27Z","timestamp":1783987767834,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY013516"],"award-info":[{"award-number":["R01 EY013516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY023285"],"award-info":[{"award-number":["R01 EY023285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Optovue,Inc."},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010313","name":"Heidelberg Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010313","name":"Heidelberg Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Optovue,Inc"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajo.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T20:57:37Z","timestamp":1550609857000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study"],"prefix":"10.1016","volume":"202","author":[{"given":"Xinbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Richard K.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Schuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2019.02.015_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2016.09.015","article-title":"Baseline fourier-domain optical coherence tomography structural risk factors for visual field progression in the Advanced Imaging for Glaucoma Study","volume":"172","author":"Zhang","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2017.12.027","article-title":"Integrating macular ganglion cell inner plexiform layer and parapapillary retinal nerve fiber layer measurements to detect glaucoma progression","volume":"125","author":"Hou","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib4","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1167\/iovs.11-7900","article-title":"A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients","volume":"53","author":"De Moraes","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.02.015_bib5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ajo.2014.11.010","article-title":"Advanced imaging for glaucoma study: design, baseline characteristics, and inter-site comparison","volume":"159","author":"Le","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.4.5.7","article-title":"Effect of signal intensity on measurement of ganglion cell complex and retinal nerve fiber layer scans in Fourier-domain optical coherence tomography","volume":"4","author":"Zhang","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2019.02.015_bib9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ophtha.2007.08.011","article-title":"Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis","volume":"115","author":"Tan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib10","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.ophtha.2009.05.025","article-title":"Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography","volume":"116","author":"Tan","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajo.2015.11.029","article-title":"Predicting development of glaucomatous visual field conversion using baseline fourier-domain optical coherence tomography","volume":"163","author":"Zhang","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ophtha.2017.01.027","article-title":"Frequency of testing to detect visual field progression derived using a longitudinal cohort of glaucoma patients","volume":"124","author":"Wu","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib13","series-title":"Clinical Decisions in Glaucoma","first-page":"52","article-title":"Clinical decisions in glaucoma","author":"Hodapp","year":"1993"},{"key":"10.1016\/j.ajo.2019.02.015_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.ajo.2019.02.015_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ophtha.2006.08.031","article-title":"Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension","volume":"114","author":"Gordon","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib16","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib21","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1167\/iovs.11-8186","article-title":"Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group","volume":"53","author":"De Moraes","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.02.015_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ophtha.2010.05.027","article-title":"Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma","volume":"118","author":"Rao","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib23","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Natural history of open-angle glaucoma","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib25","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1167\/iovs.02-0543","article-title":"The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability","volume":"44","author":"Gillespie","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.02.015_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0161-6420(99)90147-1","article-title":"The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients","volume":"106","author":"Musch","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2008.02.005","article-title":"A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients","volume":"115","author":"Heijl","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib28","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0161-6420(99)90497-9","article-title":"Early Manifest Glaucoma Trial: design and baseline data","volume":"106","author":"Leske","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.02.015_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.10.001","article-title":"Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma","volume":"56","author":"De Moraes","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2019.02.015_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/IJG.0b013e31822e8e37","article-title":"Effect of cataract extraction on visual field index in glaucoma","volume":"22","author":"Rao","year":"2013","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2019.02.015_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1167\/iovs.12-10836","article-title":"Behavior of visual field index in advanced glaucoma","volume":"54","author":"Rao","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.02.015_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5005\/jp-journals-10008-1186","article-title":"Suitability of the visual field index according to glaucoma severity","volume":"9","author":"Sousa","year":"2015","journal-title":"J Curr Glaucoma Pract"},{"key":"10.1016\/j.ajo.2019.02.015_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajo.2007.09.038","article-title":"A visual field index for calculation of glaucoma rate of progression","volume":"145","author":"Bengtsson","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib35","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1167\/iovs.11-8214","article-title":"Does optic nerve head size variation affect circumpapillary retinal nerve fiber layer thickness measurement by optical coherence tomography?","volume":"53","author":"Huang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.02.015_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bjo.2010.196782","article-title":"The influence of axial length on retinal nerve fibre layer thickness and optic-disc size measurements by spectral-domain OCT","volume":"96","author":"Savini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib37","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1167\/iovs.15-17635","article-title":"The Ability of SD-OCT to differentiate early glaucoma with high myopia from highly myopic controls and nonhighly myopic controls","volume":"56","author":"Akashi","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.02.015_bib38","first-page":"1","article-title":"Longitudinal and cross-sectional analyses of age effects on retinal nerve fiber layer and ganglion cell complex thickness by Fourier-domain OCT","volume":"5","author":"Zhang","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2019.02.015_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcjo.2012.11.001","article-title":"Effect of artificial tears on automated visual field testing in patients with glaucoma and dry eye","volume":"48","author":"Kocabeyoglu","year":"2013","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib40","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1136\/bjo.2006.104844","article-title":"Visual attention as an important visual function: an outline of manifestations, diagnosis and management of impaired visual attention","volume":"91","author":"Das","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.02.015_bib41","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.ico.0000230499.07273.c5","article-title":"Effects of glaucoma medications on corneal endothelium, keratocytes, and subbasal nerves among participants in the ocular hypertension treatment study","volume":"25","author":"Baratz","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2019.02.015_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/IJG.0b013e3181e07947","article-title":"The effect of early posttrabeculectomy intraocular pressure spike in the collaborative initial glaucoma treatment study","volume":"20","author":"Chen","year":"2011","journal-title":"J Glaucoma"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419300674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419300674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:40:02Z","timestamp":1757598002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939419300674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":42,"alternative-id":["S0002939419300674"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2019.02.015","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}